825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections

Ítems similars

• 1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
  per: Patterson, Thomas, et al.
  Publicat: (2014)
• 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
  per: Kontoyiannis, Dimitrios, et al.
  Publicat: (2014)
• 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
  per: Marty, Francisco M., et al.
  Publicat: (2014)
• Antibacterials/isavuconazole/voriconazole: Lack of efficacy: case report
  Publicat: (2020)
• Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
  per: Kovanda, Laura L., et al.
  Publicat: (2017)